The first doses of the COVID-19 vaccine would likely be given to people who are at high risk of being infected, including health care workers and senior citizens.
While no COVID-19 vaccine has been approved yet, airlines are already testing out the transportation and distribution of the vaccine in extreme temperatures.
US Operation Warp Speed backed vaccines for whole world
Brazil's Bolsonaro says won't take virus vaccine
Markets rejoiced on the news of a possible vaccine and a now-peaceful transition from Trump to Biden.
UPS stepping up dry ice production, freezers for vaccines
Russian citizens will get the Sputnik V vaccine free of charge, though the Kremlin said President Putin won’t get early access.
Moderna's and Pfizer's coronavirus vaccines may cause intense side effects, including high fever and body aches, that will often go away after 12 hours.
AstraZeneca promises virus vaccine at cost price worldwide
Three companies have touted COVID-19 vaccines with an efficacy of 70% or more. Here's how they compare.
Moderna is currently in talks with the European Commission to finalize a deal for the supply of the vaccine, wherein the latter is gunning for a price below $25.
Pfizer and its collaborator BioNTech filed for an emergency use authorization on Friday. Moderna is expected to seek authorization for its COVID-19 vaccine by the end of November.
Pfizer/BioNTech file for emergency approval for virus vaccine
Covid-19 vaccine: the next steps
Pfizer filed for emergency use authorization of their COVID-19 vaccine, meaning it could start being made available to the public sooner than previously thought.
The rapidly rising number of coronavirus cases and deaths has spurred several states to impose new curfews and restrictions to curb the spread of the virus.
Pfizer/BioNTech to seek emergency vaccine approval in US Friday
EU says could approve two coronavirus vaccines this year
December vaccine rollout possible, BioNTech CEO says
New York Mayor Bill de Blasio said the city's 1,800 public schools would revert to remote learning beginning Thursday after the Big Apple recorded a seven-day average positivity rate of 3%.
Pfizer/BioNTech say results show Covid vaccine 95% effective
We urgently need to get a safe and effective vaccine to the world," Dr. Albert Bourla, Pfizer chairman and CEO, said.